Assessing resectability for colorectal liver metastases: agreeing that we disagree  

作　　者：Luis I.Ruffolo Koji Tomiyama Roberto Hernandez-Alejandro 

机构地区：[1]Division of Abdominal Transplantation and Hepatobiliary Surgery,Department of Surgery,University of Rochester Medical Center,Rochester,NY,USA

出　　处：《Hepatobiliary Surgery and Nutrition》2020年第6期797-800,共4页肝胆外科与营养（英文）

摘　　要：Colorectal cancer(CRC)is the second leading cause of cancer related mortality,though improvements in CRC screening,systemic and local treatment,and surgical technique have steadily won victories in the battle against CRC,and the rate of mortality from CRC is steadily declining(1).However,perhaps no clinical-oncologic scenario is as unstandardized as the management of colorectal-liver metastases(CRLM)and their evaluation for consideration of resectability.

关 键 词：MORTALITY COLORECTAL METASTASES 

分 类 号：R73[医药卫生—肿瘤]